Navigation Links
Biased reporting found in cancer prognostic studies

Selective reporting biases may taint many published studies of so-called prognostic factors--biologic or genetic markers that may predict how a patient may fare during or after treatment, according to a new study in the July 20 issue of the Journal of the National Cancer Institute.

In recent years, researchers have raced to discover and publish papers on prognostic factors for cancer and other diseases. For example, at least 116 published studies alone have focused on a single tumor suppressor protein (TP53) that may predict the outcome of a patient with head and neck cancer. As researchers attempt to make sense of the growing mountains of information, some are beginning to question the validity and possible biases in many of the studies.

To examine the question of selective reporting bias, Panayiotis A. Kyzas and colleagues from the University of Ioannina in Greece analyzed information from studies that investigated the association between TP53 and mortality or survival rates. They collected three levels of information about the studies. The first level included studies that were indexed in the scientific databases MEDLINE and EMBASE using the key words "mortality" or "survival." The other two levels of collected information include published studies not indexed under "mortality" or "survival", and unpublished data retrieved from researchers.

The authors found that the association between TP53 status and head and neck cancer mortality weakened as they expanded their analyses from the 18 published and indexed studies alone to include the 13 studies with published data only. The association vanished after they added in the unpublished data from 11 studies. Additionally, 72% of 18 published meta-analyses on prognostic factors for various cancers did not use the same standard end point definitions, and 89% of them failed to retrieve all of the data from the individual studies, instead including only a sample. Both of these details may have helped
'"/>

Source:Journal of the National Cancer Institute


Page: 1 2

Related biology news :

1. Novel live reporting system to track cells
2. Careless reporting on HIV could cost lives
3. New component of the brakes on nerve regeneration found
4. Strongest proof yet found for prion hypothesis
5. A puzzle piece found in unraveling the wiring of the brain
6. New World founders small in number
7. Norovirus found to cause travelers diarrhea
8. Pair of cancer genes found to drive both cell migration and division
9. Alien woodwasp, threat to US pine trees, found in N.Y.
10. Achilles heel of the herpes virus possibly found
11. Purdue scientists may have found key to halting spinal cord damage
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biased reporting found cancer prognostic studies

(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... to remove contaminants from soil, scientists at the ... and their Belgium colleagues at Hasselt University have ... on marginal land. The findings, published in the ... Environmental Microbiology , may help scientists design strategies ...
... the FDA has approved the first human clinical trial ... considerations, but not only, or even primarily, because what ... Although deep-seated disagreements about the ethics of embryo ... to focus as well on this being the first ...
... (ACMG) will hold its 16th Annual Clinical Genetics Meeting ... at the Tampa Convention Center. Clinical and medical ... a dizzying pace and the 2009 ACMG Annual Clinical ... and scientific media to learn firsthand about the latest ...
Cached Biology News:Scientists identify bacteria that increase plant growth 2Scientists identify bacteria that increase plant growth 3Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29 2
(Date:5/26/2015)... May 26, 2015 Global Stem ... announced plans for the company’s first cellular and regenerative ... by a full day, hands-on stem cell training class ... Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) ... community’s increasing interest in regenerative medicine and recent advances ...
(Date:5/26/2015)... FORT WORTH, Texas , May 26, 2015 /PRNewswire-USNewswire/ ... North Texas Health Science Center to detect early Alzheimer,s ... screen older adults. Detailed standardized guidelines that ... in practice have been published in Alzheimer,s & ... continued efforts of an international working group that includes ...
(Date:5/26/2015)... , 26. mája 2015 ... mene svojej rodiny prezidentom Barackovi Obamovi a Billovi ... súvislosti so stratou Dr. Rongxiang Xu , ... http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu bol pionier, ... a jeho odhodlanie v oblasti vedy a príkladné ...
(Date:5/26/2015)... JERUSALEM , May 26, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has submitted the study protocol for the company,s ... to the U.S. Food and Drug Administration (FDA). The ... Drug (IND) application. The Phase IIb study ...
Breaking Biology Technology:Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... Dec. 21, 2010 Exagen Diagnostics, Inc., a specialty ... today announced that it has been awarded $400,000 in ... program, which was created by Congress as part of ...  Proceeds from the grants will be used to advance ...
... M. Golubieski, president of Foundation Venture Capital Group, LLC, ... Snowdon Inc., a company in which FVCG has invested, ... of Defense (DoD) Program, Transformational Medical Technologies (TMT). ... (DTRA) contract, Snowdon may receive up to $8.2 million ...
... knows how to make an exact cut on a metal rod. ... a carbon nanotube, with a diameter 1/50,000th the thickness of a ... British journal Proceedings of the Royal Society A , researchers ... how single-walled carbon nanotubes are cut, a finding that could lead ...
Cached Biology Technology:Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 3How do you cut a nanotube? Lots of compression 2
...
... This monoclonal antibody recognizes 30% of ... individuals. It does not cross-react ... lacking rheumatoid factor nor with pooled ... used in ELISA to detect rheumatoid ...
...
Human VEGF R2 (KDR) MAb (Clone 89106)...
Biology Products: